In his second year at the helm, Purnanand Sarma is shifting Aro Biotherapeutics' focus and wants to raise as much as $75 million in new financing.

The robotaxi company currently uses a human driver operating the vehicles in Pittsburgh but has now secured the permit to let vehicles drive themselves with a specialist behind the wheel.